David Barton
Overview
Explore the profile of David Barton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Macfarlane S, Grimmer T, Teo K, OBrien T, Woodward M, Grunfeld J, et al.
J Prev Alzheimers Dis
. 2025 Jan;
12(1):100016.
PMID: 39800452
Background: There are no approved oral disease-modifying treatments for Alzheimer's disease (AD). Objectives: The objective of this study was to assess efficacy and safety of blarcamesine (ANAVEX®2-73), an orally available...
2.
Mills N, Nikolin S, Glozier N, Barton D, Baune B, Fitzgerald P, et al.
Br J Psychiatry
. 2025 Jan;
:1-7.
PMID: 39763417
Background: Anxiety disorders and treatment-resistant major depressive disorder (TRD) are often comorbid. Studies suggest ketamine has anxiolytic and antidepressant properties. Aims: To investigate if subcutaneous racemic ketamine, delivered twice weekly...
3.
Assumpcao D, Renaud D, Baradari A, Zeng B, De-Eknamkul C, Xin C, et al.
Nat Commun
. 2024 Dec;
15(1):10459.
PMID: 39622814
Practical quantum networks will require multi-qubit quantum nodes. This in turn will increase the complexity of the photonic circuits needed to control each qubit and require strategies to multiplex memories....
4.
Ayton S, Barton D, Brew B, Brodtmann A, Clarnette R, Desmond P, et al.
JAMA Neurol
. 2024 Nov;
82(1):11-18.
PMID: 39495531
Importance: Interventions that substantially slow neurodegeneration are needed to address the growing burden of Alzheimer disease (AD) to societies worldwide. Elevated brain iron observed in AD has been associated with...
5.
Loo C, Glozier N, Barton D, Baune B, Mills N, FitzGerald P, et al.
Br J Psychiatry
. 2024 Oct;
225(2):349.
PMID: 39399907
No abstract available.
6.
Tanner R, Giacoppo D, Saber H, Barton D, Sugrue D, Roy A, et al.
Open Heart
. 2024 Mar;
11(1).
PMID: 38538065
Objective: A paucity of data exists on how transcatheter aortic valve implantation (TAVI) practice has evolved in Ireland. This study sought to analyse temporal trends in patient demographics, procedural characteristics,...
7.
Loo C, Glozier N, Barton D, Baune B, Mills N, FitzGerald P, et al.
Br J Psychiatry
. 2023 Dec;
223(6):533-541.
PMID: 38108319
Background: Prior trials suggest that intravenous racemic ketamine is a highly effective for treatment-resistant depression (TRD), but phase 3 trials of racemic ketamine are needed. Aims: To assess the acute...
8.
Croskey A, Trautman W, Barton D, Ratay M, Shulman J
Am J Emerg Med
. 2023 Nov;
75:197.e1-197.e3.
PMID: 37945412
We describe a case of a young male who presented to the emergency department with unilateral eye pain, blurred vision, conjunctival injection, and ocular pH of 9, one day after...
9.
Tanner R, Murphy S, Malone C, McGorrian C, Sugrue D, Barton D, et al.
Catheter Cardiovasc Interv
. 2022 Nov;
100(7):1316-1322.
PMID: 36403283
Objectives: To assess the correlation between the aortic valve annular plane (AVAP) obtained by preprocedural computed tomography (CT) with on-table three-dimensional rotational angiography (3DRA), in patients undergoing transcatheter aortic valve...
10.
Esler M, Alvarenga M, Barton D, Jennings G, Kaye D, Guo L, et al.
Front Psychiatry
. 2022 Jun;
13:818012.
PMID: 35722546
In research spanning three decades we have estimated brain monoamine turnover (approximately equating with synthesis rate) with sampling from the internal jugular veins and measurement of trans-cerebral plasma monoamine metabolite...